James T. Treace, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 100,000 shares at $21.36 ($2.1M) on 2023-03-01, disclosed to the SEC on 2023-03-02.
Open-market sale of $2.1M TMCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.54 | 37,316 | $804K | 37.4% |
| 2 | $21.54 | 37,316 | $804K | 37.4% |
| 3 | $21.36 | 12,684 | $271K | 12.6% |
| 4 | $21.36 | 12,684 | $271K | 12.6% |
| Total | $21.49 avg | 100,000 | $2.1M | 100% |
| Filing → |
| TMCI | BUY | 2024-05-30 | $130K | — | Filing → |
| TMCI | BUY | 2024-05-29 | $254K | — | Filing → |
| TMCI | BUY | 2024-05-13 | $1.0M | — | Filing → |